Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-24-000057
Filing Date
2024-11-12
Accepted
2024-11-12 08:36:36
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20240930.htm   iXBRL 10-Q 736922
2 EX-31.1 mlys3q2410qex311.htm EX-31.1 9816
3 EX-31.2 mlys3q2410qex312.htm EX-31.2 9753
4 EX-32.1 mlys3q2410qex321.htm EX-32.1 5057
5 EX-32.2 mlys3q2410qex322.htm EX-32.2 4961
  Complete submission text file 0001933414-24-000057.txt   3890401

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20240930.xsd EX-101.SCH 28615
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20240930_cal.xml EX-101.CAL 34962
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20240930_def.xml EX-101.DEF 115868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20240930_lab.xml EX-101.LAB 398740
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20240930_pre.xml EX-101.PRE 274066
59 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20240930_htm.xml XML 360131
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 241443778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)